Search

Premise / BY: Marshall Dahl, MD, PhD, FRCPC November 2008
... outcomes in a subset of higher-risk people with type 2 diabetes. The ACCORD study is a multi-centre, randomized ... outcomes in a subset of higher-risk people with type 2 diabetes. On 6 February 2008, the National Heart, Lung and ... the implications of this study for the treatment of type 2 diabetes. BC’s Therapeutics Initiative (TI) published a ...
Letters / BY: David C. Marsh, MD, January/February 2008
... likely to generate similar positive outcomes for society.[ 2 ] Clinical research can be an im­portant vehicle for ...
News / BY: Willem R. Vroom, MD May 2008
... Brunton et al., 2008. ISBN 0-07-144343-6, 978-0-07144343-2. $54.95. I was recently being shown around the University ...
Letters / BY: Karen A. Gelmon, MD, FRCPC September 2008
... and, more recently, evidence for radiation therapy.[ 1 , 2 ] The recommendations of the SMPBC are based on evidence. ...
BC Centre for Disease Control / BY: Fawziah Marra, PharmD December 2008
... use is a major contributing factor to resistance,[ 2 ],[ 3 ] surveillance of antibiotic use is becoming an ... are used for urinary tract infections [ Figure 2 ] and [ Figure 3 ]. Although we have shown that overall ...
Obituaries / BY: Archie Young, MDCM, March 2008
... practice in Youbou, Vancouver Island, where he stayed for 2 years. In 1950 he entered a UBC surgical residency training ...
Clinical Articles / BY: Navid Dehghani, MD, FRCPC, June 2008
... bodies, we have developed the following guidelines.[ 2 , 3 ] Ingested objects and lodgment sites Children usually ... radiograph (see  Figure 1 ) and not visible (see  Figure 2 ) can involve endoscopy. Rigid endoscopic removal under ...
Council on Health Promotion / BY: Lloyd Oppel, MD, MHSc, FCFP(Em) October 2008
... are owned by so-called big pharma. Canadians spend over $2 billion yearly on natural health products ranging from ...
Clinical Articles / BY: J.E. Albrecht, MD January/February 2008
... on mercury from  Goldfrank’s Toxicologic Emergencies .[ 2 ]  This document filled in many pieces of the puzzle, ... patient was admitted to hospital. Results were reported 2 weeks later at 2377 nmol/L (reference range < 50 ... recommended immediate therapy with a chelating agent, meso 2, 3-dimercaptosuccinic acid (DMSA or succimer).  This ...
Clinical Articles / BY: Don D. Sin, MD, MPH, FRCPC, April 2008
... 470%). • A history of COPD (this increases the risk 4.2-fold or by 320%). • Obesity (body mass index greater ... the risk 5.7-fold or by 470%).  • Surgical time of 2.5 hours or more (this increases the risk 2.9-fold or by 190%).[ 2 ]  Identification of any risk ...